How AI could speed treatment for patients with this deadly cancer

Acute myeloid leukemia, or AML, is a rare and aggressive cancer that can affect people of all ages. Kiran Vanaja, an ...
Business Insider

Novotech Publishes Research Report on Acute Myeloid Leukaemia Clinical Trial Landscape for Clinical Stage Biotechs

BOSTON, April 10, 2024 (GLOBE NEWSWIRE) -- Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of ...
Cure Today

SLS009 May Improve Survival in R/R AML

SLS009 significantly improved survival in r/r AML patients, with a median overall survival of 8.8 months, surpassing historical benchmarks. The therapy showed a 67% objective response rate in AML-MRC ...
Seeking Alpha

Moleculin Completes End of Phase 2 Meeting with FDA for Annamycin in AML

HOUSTON, July 10, 2024 /PRNewswire/ -- Moleculin Biotech, Inc. (MBRX), ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting ...